Receptor binding profile of cyclazosin, a new 1B -adrenoceptor antagonist

By Giardina D.   Crucianelli M.   Melchiorre C.   Taddei C.   Testa R.  

European Journal of Pharmacology, Vol. 287, Iss. 1, 1995-12 ,pp. : 13-16

Elsevier

Access to resources Recommend Favorite

In vivo and in vitro pharmacological studies of a new hypotensive compound (QF0301B) in rat: comparison with prazosin, a known 1 -adrenoceptor antagonist

By Orallo F.   Garcia-Ferreiro T.   Enguix M.J.   Tristan H.   Masaguer C.   Ravina E.   Cadavid I.   Loza M.I.  

General Pharmacology, Vol. 40, Iss. 2, 2003-02 ,pp. : 97-108

Elsevier

Access to resources Recommend Favorite

KMD-3213, a novel 1A -adrenoceptor antagonist, potently inhibits the functional 1 -adrenoceptor in human prostate

By Moriyama N.   Akiyama K.   Murata S.   Taniguchi J.   Ishida N.   Yamazaki S.   Kawabe K.  

European Journal of Pharmacology, Vol. 331, Iss. 1, 1997-07 ,pp. : 39-42

Elsevier

Access to resources Recommend Favorite

Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist

By Shibasaki M.   Fujimori A.   Takanashi M.   Kusayama T.   Tokioka T.   Satoh Y.   Okazaki T.   Uchida W.   Inagaki O.   Yanagisawa I.  

European Journal of Pharmacology, Vol. 335, Iss. 2, 1997-09 ,pp. : 167-173

Elsevier

Access to resources Recommend Favorite

Pharmacological profile of MEN91507, a new CysLT 1 receptor antagonist

By Cabre F.   Carabaza A.   Garca A.M.   Calvo L.   Cucchi P.   Palomer A.   Pascual J.   Garca M.L.   Manzini S.   Lecci A.   Crea A.   Maggi C.A.  

European Journal of Pharmacology, Vol. 451, Iss. 3, 2002-09 ,pp. : 317-326

Elsevier

Access to resources Recommend Favorite